Chinese Journal of Dermatology ›› 2021, Vol. 54 ›› Issue (7): 642-645.doi: 10.35541/cjd.20191018
Ying Jieya1, Xiang Wenzhong2, Song Xiuzu2
Received:2019-10-22
Revised:2020-07-28
Online:2021-07-15
Published:2021-07-02
Contact:
Xiang Wenzhong
E-mail:xiangwenzhong@126.com
Ying Jieya, Xiang Wenzhong, Song Xiuzu. Metabolic syndrome and skin diseases[J]. Chinese Journal of Dermatology, 2021, 54(7): 642-645.doi:10.35541/cjd.20191018
| ［1］ | Li R, Li W, Lun Z, et al. Prevalence of metabolic syndrome in Mainland China: a meta⁃analysis of published studies［J］. BMC Public Health, 2016,16:296. doi: 10.1186/s12889⁃016⁃2870⁃y. |
| ［2］ | Expert Panel on Detection, Evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of the national cholesterol education program （NCEP） expert panel on detection, evaluation, and treatment of high blood cholesterol in adults （adult treatment panel III）［J］. JAMA, 2001,285（19）:2486⁃2497. doi: 10.1001/jama.285.19.2486. |
| ［3］ | 中华医学会糖尿病学分会代谢综合征研究协作组. 中华医学会糖尿病学分会关于代谢综合征的建议［J］. 中华糖尿病杂志, 2004,12（3）:156⁃161. doi: 10.3321/j.issn:1006⁃6187.2004.03. 002. |
| ［4］ | Alberti KG, Zimmet P, Shaw J. Metabolic syndrome⁃⁃a new world⁃wide definition. A consensus statement from the international diabetes federation［J］. Diabet Med, 2006,23（5）:469⁃480. doi: 10.1111/j.1464⁃5491.2006.01858.x. |
| ［5］ | Leroith D. Pathophysiology of the metabolic syndrome: implications for the cardiometabolic risks associated with type 2 diabetes［J］. Am J Med Sci, 2012,343（1）:13⁃16. doi: 10.1097/MAJ.0b013e31823ea214. |
| ［6］ | 叶丰卉, 晋红中. 脂肪组织原位炎症与代谢［J］. 中华皮肤科杂志, 2017,50（2）:149⁃152. doi: 10.3760/cma.j.issn.0412⁃4030. 2017.02.031. |
| ［7］ | 魏伊秋. 慢性炎症与胰岛素抵抗机制关系的研究进展［J］. 临床与病理杂志, 2019,3（39）:196⁃201. doi: 10.3978/j.issn.2095⁃6959.2019.03.030. |
| ［8］ | Vona R, Gambardella L, Cittadini C, et al. Biomarkers of oxidative stress in metabolic syndrome and associated diseases［J］. Oxid Med Cell Longev, 2019,2019（2）:1⁃19. doi: 10.1155/2019/8267234. |
| ［9］ | Tangvarasittichai S. Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus［J］. World J Diabetes 2015,6（3）:456⁃480. doi: 10.4239/wjd.v6.i3.456. |
| ［10］ | Paschoal RS, Silva DA, Cardili RN, et al. Metabolic syndrome, C⁃reactive protein and cardiovascular risk in psoriasis patients: a cross⁃sectional study［J］. An Bras Dermatol, 2018,93（2）:222⁃228. doi: 10.1590/abd1806⁃4841.20186397. |
| ［11］ | Snekvik I, Nilsen TIL, Romundstad PR, et al. Metabolic syndrome and risk of incident psoriasis: prospective data from the HUNT Study, Norway［J］. Br J Dermatol, 2019,180（1）:94⁃99. doi: 10.1111/bjd.16885. |
| ［12］ | Kim HN, Han K, Park YG, et al. Metabolic syndrome is associated with an increased risk of psoriasis: a nationwide population⁃based study［J］. Metab Clin Exp, 2019,99:19⁃24. doi: 10.1016/j.metabol.2019.07.001. |
| ［13］ | Al Mutairi N, Alrqobah D, Haji Hussain N. Prevalence of metabolic syndrome in children with moderate to severe psoriasis treated with TNF inhibitors in comparison to conventional agents［J］. Dermatol Ther, 2018,31（1）:e12566. doi: 10.1111/dth.12566. |
| ［14］ | Xu X, Lin L, Chen P, et al. Treatment with liraglutide, a glucagon⁃like peptide⁃1 analogue, improves effectively the skin lesions of psoriasis patients with type 2 diabetes: a prospective cohort study［J］. Diabetes Res Clin Pract, 2019,150:167⁃173. doi: 10. 1016/j.diabres.2019.03.002. |
| ［15］ | 陈文娟, 彭琛, 丁杨峰, 等. 银屑病共病的研究进展［J］. 中华皮肤科杂志, 2020,53（2）:147⁃151. doi: 10.35541/cjd.20190093. |
| ［16］ | Mushtaq S, Dogra D, Dogra N, et al. Cardiovascular and metabolic risk assessment in patients with lichen planus: a tertiary care hospital⁃based study from northern India［J］. Indian Dermatol Online J, 2020,11（2）:158⁃166. doi: 10.4103/idoj.IDOJ_ 228_19. |
| ［17］ | Okpala IC, Akinboro AO, Ezejoifor IO, et al. Metabolic syndrome and dyslipidemia among Nigerians with lichen planus: a cross⁃sectional study［J］. Indian J Dermatol, 2019,64（4）:303⁃310. doi:10.4103/ijd.IJD_111_18. |
| ［18］ | Kumar SA, Krishnam Raju PV, Gopal KVT, et al. Comorbidities in lichen planus: a case⁃control study in Indian patients［J］. Indian Dermatol Online J, 2019,10（1）:34⁃37. doi: 10.4103/idoj.IDOJ_48_18. |
| ［19］ | Aktaş Karabay E, Saltık ZA, Unay Demirel Ö. Evaluation of serum FoxO1, mTORC1, IGF⁃1, IGFBP⁃3 levels and metabolic syndrome components in patients with acne vulgaris: a prospective case⁃control study［J］. Dermatol Ther, 2020:e13887. doi: 10.1111/dth.13887. |
| ［20］ | Nagpal M, De D, Handa S, et al. Insulin resistance and metabolic syndrome in young men with acne［J］. JAMA Demtol, 2016,152（4）:399⁃404. doi: 10.1001/jamadermatol.2015.4499. |
| ［21］ | Franik G, Bizoń A, Włoch S, et al. Hormonal and metabolic aspects of acne vulgaris in women with polycystic ovary syndrome［J］. Eur Rev Med Pharmacol Sci, 2018,22（14）:4411⁃4418. doi: 10.26355/eurrev_201807_15491. |
| ［22］ | Akin Belli A, Ozbas Gok S, Akbaba G, et al. The relationship between rosacea and insulin resistance and metabolic syndrome［J］. Eur J Dermatol, 2016,26（3）:260⁃264. doi: 10.1684/ejd.2016. 2748. |
| ［23］ | Rainer BM, Fischer AH, Luz Felipe da Silva D, et al. Rosacea is associated with chronic systemic diseases in a skin severity⁃dependent manner: results of a case⁃control study［J］. J Am Acad Dermatol, 2015,73（4）:604⁃608. doi: 10.1016/j.jaad.2015. 07.009. |
| ［24］ | Phan K, Charlton O, Smith SD. Hidradenitis suppurativa and metabolic syndrome ⁃ systematic review and adjusted meta⁃analysis［J］. Int J Dermatol, 2019,58（10）:1112⁃1117. doi:10. 1111/ijd.14500. |
| ［25］ | Golbari NM, Porter ML, Kimball AB. Antiandrogen therapy with spironolactone for the treatment of hidradenitis suppurativa［J］. J Am Acad Dermatol, 2019,80（1）:114⁃119. doi: 10.1016/j.jaad. 2018.06.063. |
| ［26］ | González⁃López MA, Vilanova I, Ocejo⁃Viñals G, et al. Circulating levels of adiponectin, leptin, resistin and visfatin in non⁃diabetics patients with hidradenitis suppurativa［J］. Arch Dermatol Res, 2019,312（8）:595⁃600. doi: 10.1007/s00403⁃019⁃02018⁃4. |
| ［27］ | Swaroop MR, Kumar BM, Sathyanarayana BD, et al. The association of metabolic syndrome and insulin resistance in early⁃onset androgenetic alopecia in males: a case⁃control study［J］. Indian J Dermatol, 2019,64（1）:23⁃27. doi: 10.4103/ijd.IJD_724_16. |
| ［28］ | El Sayed MH, Abdallah MA, Aly DG, et al. Association of metabolic syndrome with female pattern hair loss in women: a case⁃control study［J］. Int J Dermatol, 2016,55（10）:1131⁃1137. doi: 10.1111/ijd.13303. |
| ［29］ | Misitzis A, Cunha PR, Kroumpouzos G. Skin disease related to metabolic syndrome in women［J］. Int J Womens Dermatol, 2019,5（4）:205⁃212. doi: 10.1016/j.ijwd.2019.06.030. |
| ［30］ | Lee S, Lee H, Lee CH, et al. Comorbidities in alopecia areata: a systematic review and meta⁃analysis［J］. J Am Acad Dermatol, 2019,80（2）:466⁃477.e16. doi: 10.1016/j.jaad.2018.07.013. |
| ［31］ | Shahidi⁃Dadras M, Bahraini N, Rajabi F, et al. Patients with alopecia areata show signs of insulin resistance［J］. Arch Dermatol Res, 2019,311（7）:529⁃533. doi: 10.1007/s00403⁃019⁃01929⁃6. |
| ［32］ | Schiffrin EL. Immune mechanisms in hypertension and vascular injury［J］. Clin Sci, 2014,126（4）:267⁃274. doi: 10.1042/CS2013 0407. |
| ［33］ | Shalom G, Dreiher J, Kridin K, et al. Atopic dermatitis and the metabolic syndrome: a cross⁃sectional study of 116 816 patients［J］. J Eur Acad Dermatol Venereol, 2019,33（9）:1762⁃1767. doi: 10.1111/jdv.15642. |
| ［34］ | Shalom G, Magen E, Babaev M, et al. Chronic urticaria and the metabolic syndrome: a cross⁃sectional community⁃based study of 11 261 patients［J］. J Eur Acad Dermatol Venereol, 2018,32（2）:276⁃281. doi: 10.1111/jdv.14548. |
| ［35］ | Vena GA, Cassano N. The link between chronic spontaneous urticaria and metabolic syndrome［J］. Eur Ann Allergy Clin Immunol, 2017,49（5）:208⁃212. doi: 10.23822/EurAnnACI.1764⁃1489.12. |
| ［36］ | Sharma YK, Bansal P, Menon S, et al. Metabolic syndrome in vitiligo patients among a semi⁃urban Maharashtrian population: a case control study［J］. Diabetes Metab Syndr, 2017,11:S77⁃S80. doi: 10.1016/j.dsx.2016.12.009. |
| ［37］ | Tanacan E, Atakan N. Higher incidence of metabolic syndrome components in vitiligo patients: a prospective cross⁃sectional study［J］. An Bras Dermatol, 2020,95（2）:165⁃172. doi: 10.1016/j.abd.2019.07.006. |
| ［38］ | Seremet S, Gurel MS. Miscellaneous skin disease and the metabolic syndrome［J］. Clin Dermatol, 2018,36（1）:94⁃100. doi: 10.1016/j.clindermatol.2017.09.016. |
| ［39］ | Singh SK, Agrawal NK, Vishwakarma AK. Association of acanthosis nigricans and acrochordon with insulin resistance: a cross⁃sectional hospital⁃based study from north India［J］. Indian J Dermatol, 2020,65（2）:112⁃117. doi: 10.4103/ijd.IJD_646_18. |
| ［40］ | Hallajzadeh J, Khoramdad M, Izadi N, et al. The association between metabolic syndrome and its components with systemic lupus erythematosus: a comprehensive systematic review and meta⁃analysis of observational studies［J］. Lupus, 2018,27（6）:899⁃912. doi: 10.1177/0961203317751047. |
| ［41］ | Lesniewska A, Kalińska⁃Bienias A, Kowalewski C, et al. Development of bullous pemphigoid in a patient with psoriasis and metabolic syndrome［J］. Cutis, 2016,98（3）:E19. |
| ［42］ | Petermann Smits DR, Wilde B, Kianersi Adegani M, et al. Metabolic syndrome in ANCA⁃associated vasculitis［J］. Rheumatology （Oxford）, 2013,52（1）:197⁃203. doi: 10.1093/rheumatology/kes345. |
| ［43］ | Nagase T, Akase T, Sanada H, et al. Aging⁃like skin changes in metabolic syndrome model mice are mediated by mineralocorticoid receptor signaling［J］. Aging Cell, 2013,12（1）:50⁃57. doi: 10.1111/acel.12017. |
| ［44］ | Nagel G, Bjørge T, Stocks T, et al. Metabolic risk factors and skin cancer in the metabolic syndrome and cancer project （Me⁃Can）［J］. Br J Dermatol, 2012,167（1）:59⁃67. doi: 10.1111/j. 1365⁃2133.2012.10974.x. |
| [1] | Wang Xiaowen, Li Ruoyu. Superficial fungal infections in psoriasis patients treated with IL-17 related biological agents and their management [J]. Chinese Journal of Dermatology, 2022, 55(3): 272-275. |
| [2] | Fu Chao, Wu Jiaona, Lang Wenchao, Gao Fei, Niu Guiye, Bian Peiwen, Gao Minhong, Si Xiaoqing, Xin Linlin. Role of dermoscopy in assessing vitiligo activity [J]. Chinese Journal of Dermatology, 2022, 55(3): 268-271. |
| [3] | Writing committee expert group on “diagnosis and treatment of pustular psoriasis: a Chinese expert consensus statement”. Diagnosis and treatment of pustular psoriasis: a Chinese expert consensus statement （2022） [J]. Chinese Journal of Dermatology, 2022, 55(3): 187-195. |
| [4] | Wu Shuhui, Zhu Mingfang, Zhang Xi, Yang Yixuan, Zhang Juanjuan. Effect of milk on sebaceous gland spots and the IGF-1/SREBP-1/ACC-1 signaling pathway in golden hamsters [J]. Chinese Journal of Dermatology, 2022, 55(3): 238-242. |
| [5] | Wang Yue, Yan Yulin. Analysis of adverse drug reactions and reasons for drug discontinuation during acitretin therapy in 171 patients with psoriasis vulgaris [J]. Chinese Journal of Dermatology, 2022, 55(3): 242-245. |
| [6] | Li Yan, Li Ming, Xu Wei, Li Linfeng. Efficacy of fluticasone propionate cream alone or in combination with calcipotriol ointment in the treatment of mild to moderate plaque psoriasis: a randomized self-controlled study [J]. Chinese Journal of Dermatology, 2022, 55(3): 260-263. |
| [7] | Wang Zhaoyang, Chen Anwei, Xiang Xin, Luo Xiaoyan, Xu Zigang, Wang Hua, Ma Lin. An investigation into the current situation of pediatric psoriasis based on the information systems from two children′s hospitals [J]. Chinese Journal of Dermatology, 2022, 55(3): 246-250. |
| [8] | Ainiwaer·Talifu, Xiong Cheng, Refuhati·Saimaiti, Yusufu·Maitinuer, Tuerxun·Wufuer, Akenmujiang·Aierken, Julaiti·Abuduwayiti, Maimaitiaili·Kade. Identification and analysis of differentially expressed genes in vitiligo using bioinformatics methods [J]. Chinese Journal of Dermatology, 2022, 0(2): 20200391-e20200391. |
| [9] | Zhang Tingting, Zhu Fengyi, Yang Mei, Zhang Ping, Xia Ping, Zhou Xiaoyong. Clinical efficacy and safety of secukinumab in the treatment of 7 cases of erythrodermic psoriasis [J]. Chinese Journal of Dermatology, 2022, 0(2): 20210644-e20210644. |
| [10] | Zhang Guoyi, Gong Xiangdong, Zhu Bokun, Liu Chuanxia, Jing Linghua, Xu Jinyu. Patterns of skin diseases among outpatients attending Hospital of Dermatology of Chinese Academy of Medical Sciences in 2019 [J]. Chinese Journal of Dermatology, 2022, 55(2): 150-152. |
| [11] | Ou Min, Yan Yunling, Zheng Baoqing, Wang Xiaohua. Correlations between psoriasis and obesity [J]. Chinese Journal of Dermatology, 2022, 55(2): 181-184. |
| [12] | Jiang Peiyu, Zhang Jiawen, Liu Zijing, Wang Xiaoyan, Liu Yunyi, Liu Yixuan, Xu Yang. Basic principles of photobiomodulation and its application in dermatology [J]. Chinese Journal of Dermatology, 2022, 55(1): 84-87. |
| [13] | Gao Rong, Zhang Lan, Li Zhengxiao. Biological agents in the treatment of moderate to severe plaque psoriasis and psoriatic arthritis [J]. Chinese Journal of Dermatology, 2022, 55(1): 72-75. |
| [14] | Zhao Ying, Wang Juanjuan, Ji Jiang, Su Wenxing, Wei Yuqian, Leng Hong, Ding Yujie, Shi Xin. Interleukin-17A-mediated psoriasis and cardiovascular comorbidities [J]. Chinese Journal of Dermatology, 2022, 55(1): 76-79. |
| [15] | Chinese Society of Dermatology, China Dermatologist Association. Consensus on the diagnosis and treatment of autoimmune subepidermal bullous diseases （2022） [J]. Chinese Journal of Dermatology, 2022, 55(1): 1-11. |
|
